Aetna selects Millennium Laboratories as national pain management services provider

Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today a national agreement with Aetna, one of the nation’s leading diversified health care benefits companies that serves approximately 36.3 million people. Under the terms of the three-year ancillary services agreement which went into effect February 1, 2010, Millennium Laboratories’ will assist Aetna participating physicians nationwide with state-of-the-art therapeutic drug monitoring services and tools. These will help physicians better manage their patients’ pain while at the same time aiding compliance with pain medication regimens.

James Slattery, Millennium Laboratories CEO, commented, “We are proud to have been selected by Aetna as a national pain management services provider. Aetna’s support of therapeutic drug monitoring services for their participating physicians advances urine drug screening as a standard of care to ensure patients have quality pain management. As a leader in this field, pain physicians know they can rely on Millennium Laboratories as we provide the fastest turn-around time in the industry for drug test reporting and final confirmation of results because we exclusively utilize the latest cutting-edge technology, Liquid Chromatography/Mass Spectrometry/Mass Spectrometry (LC-MS/MS).”